Blog - Page 33 of 39 - Omega Healthcare

News & Blog

Tumor Tip header image
Tumor Tip of the Week-Lymphovascular Invasion and Neoadjuvant Therapy

Scenario: 2022 Question:  How would you code Lymphovascular invasion? Answer:   9 Rationale: STORE 2022 f. For cases treated with neoadjuvant therapy, refer to table below

  • Omega Healthcare
  • 22 August

Tumor Tip header image
Tumor Tip of the Week-Kidney Single Tumor with 2 or variants of that NOS

Scenario: 2022 diagnosis is a single tumor with renal cell carcinoma (RCC) 8312, papillary renal cell carcinoma 8260, and mucinous tubular and spindle cell carcinoma

  • Omega Healthcare
  • 16 August

Tumor Tip header image
Tumor Tip of the Week-Pericolonic/Pericolorectal tissue Invaded-Reg or Local

#1 Scenario: 2022 pT3 pN0 cM0 Stage IIA Transverse Colon with Extension through the wall into pericolic tissue, 16 nodes (-), no mets on CT.

  • Omega Healthcare
  • 01 August

Press Release header image
Omega Healthcare Named “Star Performer” in RCM Operations PEAK Matrix® Assessment 2022

Omega Healthcare Named “Star Performer” in Revenue Cycle Management (RCM) Operations PEAK Matrix® Assessment 2022 Marks the fifth year that Omega has been ranked as

  • Omega Healthcare
  • 18 July

Tumor Tip header image
Tumor Tip of the Week-Multiple Papillary and Multiple Follicular Ca of the Thyroid-Single or Multiple Primary?

Question:  If you had multiple papillary tumors such as a micropapillary 8260/3 and a papillary tall cell 8344/3 would we apply rule M6 (single primary)

  • Omega Healthcare
  • 18 July

Tumor Tip header image
Tumor Tip of the week: Cirrhosis-Fibrosis Score

Scenario: 2022 patient presents to facility and biopsy of liver shows hepatocellular carcinoma scans reveal changes of hepatic cirrhosis, no further workup done, patient expires.

  • Omega Healthcare
  • 05 July